Skip to main content

Table 1 Bivariate analyses of factors associated with methadone doses among 158 methadone-treated PWID in Thailand

From: Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study

Characteristic

Total n (%) 158 (100)

Methadone dosageb

p value

Methadone dosageb

p value

≥ 60 mg/dayn (%)16 (10.1)

< 60 mg/dayn (%)142 (89.9)

> 30 mg/dayn (%)78 (49.4)

≤ 30 mg/dayn (%)80 (50.6)

Age (median, IQR)

38 (34–48)

36 (34–44)

38 (34–48)

0.273

37 (33–46)

40 (35–51)

0.027

Male gender

131 (82.9)

13 (81.2)

118 (90.1)

0.739c

65 (83.3)

66 (82.5)

0.889

HIV-positive

30 (19.0)

7 (43.8)

23 (16.2)

0.015c

18 (23.1)

12 (15.0)

0.196

Daily heroin injectiond

22 (13.9)

1 (6.3)

21 (14.8)

0.701c

11 (14.1)

11 (13.8)

0.949

Daily midazolam injectiond

76 (48.1)

8 (50.0)

68 (47.9)

0.873

39 (50.0)

37 (46.3)

0.637

Daily methamphetamine injectiond

7 (4.4)

0 (0.0)

7 (4.9)

N/A

4 (5.1)

3 (3.8)

0.718c

Daily methadone injectiond

23 (14.6)

2 (12.5)

21 (14.8)

>0.999c

13 (16.7)

10 (12.5)

0.458

Syringe sharingd

30 (19.0)

2 (12.5)

28 (19.7)

0.738c

13 (16.7)

17 (21.3)

0.463

Ever acquired street methadone because prescribed dosages of methadone were too low

25 (15.8)

3 (18.8)

22 (15.5)

0.721c

16 (20.5)

9 (11.3)

0.111

Duration of methadone treatmenta

 < 1 month

4 (2.5)

0 (0.0)

4 (2.8)

N/A

1 (1.3)

3 (3.8)

N/A

 ≥ 1 month, < 6 months

26 (16.5)

2 (12.5)

24 (16.9)

 

10 (12.8)

16 (20.0)

 

 ≥ 6 months, < 12 months

11 (6.7)

0 (0.0)

11 (7.7)

 

6 (7.7)

5 (6.3)

 

 ≥ 12 month

115 (72.8)

14 (87.5)

101 (71.1)

 

60 (76.9)

55 (68.8)

 
  1. PWID people who inject drugs, IQR interquartile range
  2. aNumbers do not add up to 158 due to missing observations (n = 2)
  3. bAt the most recent time they received methadone
  4. cFisher’s exact test
  5. dRefers to the previous 6 months